Vallon Pharmaceuticals, Inc. (VLON): Price and Financial Metrics
VLON Price/Volume Stats
| Current price | $12.00 | 52-week high | $12.92 |
| Prev. close | $0.46 | 52-week low | $0.21 |
| Day low | $11.41 | Volume | 37,113 |
| Day high | $12.92 | Avg. volume | 5,783,646 |
| 50-day MA | $0.47 | Dividend yield | N/A |
| 200-day MA | $0.38 | Market Cap | 161.78M |
VLON Stock Price Chart Interactive Chart >
Vallon Pharmaceuticals, Inc. (VLON) Company Bio
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of prescription drugs for central nervous system disorders. The company develops abuse-deterrent amphetamine immediate-release, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. It also develops ADMIR, an abuse deterrent formulation of Ritalin. The company was incorporated in 2018 and is based in Philadelphia, Pennsylvania.
Latest VLON News From Around the Web
Below are the latest news stories about VALLON PHARMACEUTICALS INC that investors may wish to consider to help them evaluate VLON as an investment opportunity.
Vallon Pharmaceuticals down 9% on merger with GRI Bio and reverse stock split
|
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time for a dive into the latest stock market happenings with the biggest pre-market stock movers worth watching on Friday! |
Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.Combined company will operate as GRI Bio, Inc. and advance innovative pipeline of Natural Killer T (“NKT”) modulating therapies for the treatment of inflammatory, fibrotic and autoimmune diseasesInvestment proceeds expected to fund planned operations of the combined company into mid-2024 Trading on Nasdaq under the ticker symbol “GRI” expected to commence April 24, 2023 PHILADELPHIA, PA, April 21, 2023 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: VLON), (“GRI,” “GRI Bio,” or the “Company”), today |
Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock SplitVallon’s board approves 1-for-30 reverse stock split Merger expected to close April 21, 2023 PHILADELPHIA, PA, April 20, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) (“Vallon” or the “Company”) today announced that its stockholders have approved Proposals 1, 2, 4 and 5, related to the previously announced proposed merger with GRI Bio, Inc., a privately held biotechnology company (“GRI Bio” or “GRI”), at a special meeting of stockholders held on April 20, 2023 (the “Specia |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time for another dive into the biggest pre-market stock movers as we see what's moving the market on Thursday morning! |
VLON Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -73.54% |
| 5-year | N/A |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -85.45% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...